KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- Pharmacy Centralization Creates More Opportunities for Pharmacists | NCPDP 2025 May 13, 2025Vin Gupta, MD, discusses trends and perspectives in patient data privacy as well as what a “smart pharmacy” may look like in the near future.
- Pneumococcal, Flu Vaccination Rates Low in Patients With Psychiatric Disorders May 13, 2025Patients with psychosis, depression, and anxiety exhibit higher rates of vaccine hesitancy.
- Pharmacists Must Stay Knowledgeable on Evolving IRA Provisions | NCPDP 2025 May 13, 2025Greg Miller, RPh, discussed the past, present, and future of the Inflation Reduction Act and key insights pharmacists should understand in order to keep up with the legislation.
- What Recent PBM Updates Mean for Pharmacy in 2025 | NCPDP 2025 May 12, 2025Cami Agena, Esq, and Candida Ruesga, Esq, discuss pharmacy benefit manager reform by providing insights from their experience as legal partners in complex PBM matters.
- Icotrokinra Shows High Rates of Skin Clearance in Scalp, Genital Psoriasis May 12, 2025In a phase 3 study, 57% of patients treated with icotrokinra achieved an Investigator's Global Assessment score of 1 or 0 and a grade 2 or more improvement at week 16.
- Tirzepatide Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial May 12, 2025Tirzepatide (Zepbound) demonstrated superiority compared to semaglutide (Wegovy) across the primary end point and 5 key secondary end points.
- How Pharmacists Are Becoming More Connected as Providers Through Interoperability | NCPDP 2025 May 12, 2025Larry King, PharmD, discusses how pharmacy interoperability is working to create collaborative care and get pharmacists “in the game” as he says.
- President Trump Signs Executive Order Significantly Decreasing US Drug Prices May 12, 2025The order is set to make patients’ prescription costs similar to other nations with the lowest-priced drugs in the world.
- Lifestyle Factors Contribute to Risk of Diabetic Nephropathy May 12, 2025Investigators find that unhealthy eating and inadequate or excessive sleeping duration could contribute to developing diabetic nephropathy.
- Q&A: Douglas Hoey on How Rite Aid’s Closure Will Impact Independent Pharmacies May 12, 2025Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chain’s situation means for the pharmacy landscape.
Pharmacy Times articles
- Mild to Moderate Adverse Events Possible in Pediatric Patients With Primary Immunodeficiency Receiving IVIG May 13, 2025Despite being an effective treatment option, intravenous immunoglobulin (IVIG) can cause transient adverse events in pediatrics with primary immunodeficiency, including headache and fever.
- May 2025 Pharmacy Policy May 13, 2025
- Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP May 13, 2025
- Research Suggests Natural Supplementation Could Decrease Biological Age May 13, 2025A natural aging supplement enhances muscle strength and reduces biological age, promoting healthier aging.
- Leveraging AI Within Rare Disease Care While Maintaining Humanity May 13, 2025Artificial intelligence (AI) can transform rare disease research by leveraging patient data, enhancing evidence generation, and improving communication between patients and health care professionals.
- Multicomponent COVID-19-Influenza Vaccine Induces Higher Immune Responses Than Standard Care Immunizations May 12, 2025A new multicomponent vaccine, mRNA-1083, shows promise in enhancing immune responses against influenza and COVID-19, addressing vaccine hesitancy effectively.
- Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management May 12, 2025Explore the latest insights on emerging antibody drug conjugates for HER2 breast cancer and real-world management strategies.
- Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension May 12, 2025Maternal cardiometabolic issues during pregnancy significantly elevate children's blood pressure, highlighting the need for preventive health measures.
- Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management May 12, 2025Pharmacists are positioned to significantly impact weight management by offering accessible expertise in medication, lifestyle guidance, and long-term support for healthier choices.
- Patient-Centered Value is Essential Within Health Care Research May 12, 2025During a panel discussion, 3 experts highlighted ways health care professionals and researchers can help provide patient-centered care.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com